LABTVSLH• 12 Months (Normalized)
LABT vs LH (Lakewood-Amedex Biotherapeutics Inc. vs Labcorp Holdings Inc.)
Showing Closing Date Range from Sep, 16, 2025 to Sep, 16, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
LABT Performance $2.09
-97.58%
Lakewood-Amedex Biotherapeutics Inc.
Normalized Baseline0.00%
LH Performance $324.51
+18.4%
Labcorp Holdings Inc.
Normalized Baseline0.00%
Alpha Spread Margin LH LEADS
-115.98%
LH outperforming by 115.98%
LABTLH
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
LABT LH
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(252 dates)
| Date | LABT Price | LABT Gain (%) | LH Price | LH Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 16, 2026 | $2.09 | -97.58% | $324.51 | +18.40% | -115.98% |
| Sep 15, 2026 | $2.17 | -97.49% | $323.97 | +18.20% | -115.69% |
| Sep 14, 2026 | $2.12 | -97.55% | $315.31 | +15.04% | -112.59% |
| Sep 11, 2026 | $2.22 | -97.43% | $311.54 | +13.66% | -111.09% |
| Sep 10, 2026 | $2.05 | -97.63% | $306.96 | +11.99% | -109.62% |
| Sep 09, 2026 | $2.32 | -97.32% | $321.10 | +17.15% | -114.47% |
| Sep 08, 2026 | $2.18 | -97.48% | $324.86 | +18.52% | -116.00% |
| Sep 04, 2026 | $1.88 | -97.83% | $326.89 | +19.26% | -117.09% |
| Sep 03, 2026 | $1.90 | -97.80% | $331.50 | +20.95% | -118.75% |
| Sep 02, 2026 | $2.07 | -97.61% | $331.66 | +21.00% | -118.61% |
| Sep 01, 2026 | $2.76 | -96.81% | $327.61 | +19.53% | -116.34% |
| Aug 31, 2026 | $2.50 | -97.11% | $332.66 | +21.37% | -118.48% |
| Aug 28, 2026 | $2.30 | -97.34% | $335.11 | +22.26% | -119.60% |
| Aug 27, 2026 | $2.49 | -97.12% | $336.54 | +22.78% | -119.90% |
| Aug 26, 2026 | $2.45 | -97.17% | $335.72 | +22.49% | -119.66% |
Page 1 of 17